Close
Close
Treatment Database
Lenalidomide
Trade Name Revlimid
Orphan Indication Mantle cell lymphoma
EU Market Approval 12-07-2016
EU Designation Date 27-10-2011
Sponsor Celgene Europe B.V.
More about Mantle cell lymphoma
Free Newsletter
Related Videos
by Abidemi Uruejoma
9,302 views
by Abidemi Uruejoma
9,804 views
by Abidemi Uruejoma
10,397 views